Asparec

Asparec Uses, Dosage, Side Effects, Food Interaction and all others data.

Asparec is under investigation in clinical trial NCT02257684 (A Dose Confirmation and Pharmacokinetic Study of Asparec Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)).

Trade Name	Asparec
Generic	Pegcrisantaspase
Pegcrisantaspase Other Names	Asparec, Mpeg-r-crisantaspase, Pegcrisantaspase, Pegylated dickeya chrysanthemi l-asparaginase, Pegylated erwinia chrysanthemi l-asparaginase
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here Asparec